Cardio ‐renal protective effect of SGLT2 inhibitors and mitochondrial function
This article is protected by copyright. All rights reserved.
Source: Journal of Diabetes Investigation - Category: Endocrinology Authors: Hong Kyu Lee Tags: Editorial Source Type: research
More News: Canagliflozin | Cardiology | Cardiovascular | Clinical Trials | Dapagliflozin | Diabetes | Diabetes Type 2 | Empagliflozin | Endocrinology | Forxiga | Heart | Heart Attack | Heart Failure | Invokana | Jardiance | SGLT2 Inhibitors | Sodium | Study